Please provide your email address to receive an email when new articles are posted on . Asymptomatic brain lesions were rarely observed on conventional MRI in patients with clinically stable, antibody ...

"Our study showed that changes in thalamic volume correlates with fatigue severity. To the best of our knowledge, this study is the first to identify the MRI substrate of fatigue in patients with ...

Neuromyelitis optica spectrum disorder (NMOSD), an inflammatory disease of the central nervous system, manifests as optic neuritis, myelitis, and certain brain and brainstem syndromes. Recent ...

BARCELONA, Spain — For the first time in a decade, diagnostic criteria for neuromyelitis optica spectrum disorder (NMOSD) are being overhauled, with changes that redefine the condition and its ...

There are predominantly 2 patterns of NMOSD: monophasic and relapsing. Monophasic NMOSD is diagnosed in approximately 10% of patients and occurs when 1 or both optic nerves and spinal cord are ...

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that mostly affects your eyes and spinal cord. Your immune system attacks a specific protein, called aquaporin-4 (AQP4). The ...

AstraZeneca today announced a strategic regional collaboration with the Middle East North Africa Committee for Treatment and ...

NATIONAL HARBOR, Md. — Treating neuromyelitis optica spectrum disorder (NMOSD) with the recently approved monoclonal antibody inebilizumab (Uplizna, Horizon Therapeutics) is effective across patient ...

ALBUQUERQUE, N.M. — In New Mexico, March is Neuromyelitis Optica Spectrum Disorder Awareness Month. It’s a rare disease that impacts the central nervous system. Tonight, the DoubleTree hotel in ...

-- The “NMOSD Won’t Stop Me” initiative aims to bring the community together through storytelling during NMO Awareness Month and beyond -- DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: ...